BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10542418)

  • 1. Regulation of virulence factor expression in group A streptococcus.
    Wessels MR
    Trends Microbiol; 1999 Nov; 7(11):428-30. PubMed ID: 10542418
    [No Abstract]   [Full Text] [Related]  

  • 2. To be capsulated or not be capsulated: that is the GAS question.
    Creti R; Gherardi G; Imperi M
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2381-2383. PubMed ID: 31410623
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.
    Levin JC; Wessels MR
    Mol Microbiol; 1998 Oct; 30(1):209-19. PubMed ID: 9786197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos.
    Schmidt KH; Günther E; Courtney HS
    Med Microbiol Immunol; 1996 Feb; 184(4):169-73. PubMed ID: 8811648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the cysteine protease SpeB affects hyaluronic acid capsule expression in group A streptococci.
    Woischnik M; Buttaro BA; Podbielski A
    Microb Pathog; 2000 Apr; 28(4):221-6. PubMed ID: 10764613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen-dependent phenotypic variation in group A streptococcus.
    Chiang-Ni C; Nian SY; Wu JJ; Chen CJ
    J Microbiol Immunol Infect; 2016 Dec; 49(6):837-842. PubMed ID: 25649484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M protein expression is not required for resistance to phagocytosis of type 18 group A streptococci.
    Liu S; Courtney HS; Bessen DE; Hasty DL; Dale JB
    Adv Exp Med Biol; 1997; 418():725-7. PubMed ID: 9331754
    [No Abstract]   [Full Text] [Related]  

  • 8. [Virulence factors in Streptococcus pyogenes infection].
    Kawabata S
    Nihon Saikingaku Zasshi; 2005 May; 60(2):365-74. PubMed ID: 15966363
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenotypic Variation in the Group A
    Sarkar P; Danger JL; Jain I; Meadows LA; Beam C; Medicielo J; Burgess C; Musser JM; Sumby P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.
    Kwinn LA; Khosravi A; Aziz RK; Timmer AM; Doran KS; Kotb M; Nizet V
    J Bacteriol; 2007 Feb; 189(4):1322-9. PubMed ID: 17114267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hyaluronic acid capsule production by the has operon promoter in group A streptococci.
    Alberti S; Wessels MR
    Adv Exp Med Biol; 1997; 418():975-8. PubMed ID: 9331813
    [No Abstract]   [Full Text] [Related]  

  • 12. Group A streptococcus and host metabolism: virulence influences and potential treatments.
    Baruch M; Hertzog BB; Ravins M; Youting CC; Hanski E
    Future Microbiol; 2014; 9(6):713-6. PubMed ID: 25046517
    [No Abstract]   [Full Text] [Related]  

  • 13. Phosphorylation of the group A Streptococcal CovR response regulator causes dimerization and promoter-specific recruitment by RNA polymerase.
    Gusa AA; Gao J; Stringer V; Churchward G; Scott JR
    J Bacteriol; 2006 Jul; 188(13):4620-6. PubMed ID: 16788170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DNA arrays to identify a mutation in the negative regulator, csrR, responsible for the high virulence of a naturally occurring type M3 group A streptococcus clinical isolate.
    Miyoshi-Akiyama T; Ikebe T; Watanabe H; Uchiyama T; Kirikae T; Kawamura Y
    J Infect Dis; 2006 Jun; 193(12):1677-84. PubMed ID: 16703511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of virulence gene expression in Streptococcus pyogenes: determinants of differential mRNA decay.
    Bugrysheva JV; Scott JR
    RNA Biol; 2010; 7(5):569-72. PubMed ID: 21037420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci.
    Cleary PP; McLandsborough L; Ikeda L; Cue D; Krawczak J; Lam H
    Mol Microbiol; 1998 Apr; 28(1):157-67. PubMed ID: 9593304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative comparison of virulence traits, including murine lethality, among different M types of group A streptococci.
    Miyoshi-Akiyama T; Zhao J; Kikuchi K; Kato H; Suzuki R; Endoh M; Uchiyama T
    J Infect Dis; 2003 Jun; 187(12):1876-87. PubMed ID: 12792864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface.
    Dinkla K; Sastalla I; Godehardt AW; Janze N; Chhatwal GS; Rohde M; Medina E
    Microbes Infect; 2007 Jul; 9(8):922-31. PubMed ID: 17544803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of binding sites for the group A streptococcal global regulator CovR.
    Federle MJ; Scott JR
    Mol Microbiol; 2002 Mar; 43(5):1161-72. PubMed ID: 11918804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementation of a speA negative Streptococcus pyogenes with speA: effects on virulence and production of streptococcal pyrogenic exotoxin A.
    Unnikrishnan M; Cohen J; Sriskandan S
    Microb Pathog; 2001 Sep; 31(3):109-14. PubMed ID: 11500096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.